Zaloguj się

Gotowe bibliografie tematyczne / HCV / Książki

Książki na temat „HCV”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: HCV.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 6 września 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „HCV”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. New York: Community Prescription Service, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Dammacco, Franco, red. HCV Infection and Cryoglobulinemia. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-1705-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Milano: Springer-Verlag Italia, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Musharraf, Husain, i Population Council (Bangladesh), red. Prevalence of HIV, HBV, HCV and syphilis markers in pregnant women of Bangladesh. Dhaka, Bangladesh: Population Council, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Okita, Kiwamu, red. HCV and Related Liver Diseases. Tokyo: Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-68488-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Jürgens, Ralf. HIV/AIDS and HCV in prisons: A select annotated bibliography. Ottawa, Ont: International Affairs Directorate, Health Canada, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Okita, Kiwamu, red. HCV/Oxidative Stress and Liver Disease. Tokyo: Springer Japan, 2003. http://dx.doi.org/10.1007/978-4-431-67005-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Kiwamu, Okita, red. HCV/oxidative stress and liver disease. Tokyo: Springer, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

name, No. HCV/oxidative stress and liver disease. Tokyo: Springer, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Sofia, Michael J., red. HCV: The Journey from Discovery to a Cure. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28400-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Sofia, Michael J., red. HCV: The Journey from Discovery to a Cure. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28207-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Dirgahayu, Paramasari. Molecular epidemiology database of HIV, HBV, HCV, HDV, HTLV-1/2, and TTV in Central of Java, Indonesia: Final report international research collaboration and international publication. [Surakarta]: Sebelas Maret Univ., 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Association, Canadian Hospital, red. Guide to policies for health care facilities and agencies: Bloodborne pathogens, especially Human Immunodeficiency Virus (HIV), Hepatitis B Virus, (HBV) and Hepatitis C Virus (HCV). Ottawa, Ont: Canadian Hospital Association, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

G, Gish Robert, red. Maximizing the benefits of antiviral therapy for HCV: The advantages of treating side effects. Philadelphia: W.B. Saunders, 2004.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Duncan, Tim. Conquering Hepatitis C and surviving treatment: An essential guide through every step of the HCV treatment process. [Place of publication not identified]: T. Duncan, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Giulio, Pisani, red. Nucleic acid amplification technology (NAT) for the detection of Hepatitis C Virus (HCV) in plasma pools: Validation report. Roma: Istituto superiore di sanità, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Mohamed Hatem Fathi El-Saied Wali. Natural history, factors affecting severity and progression rate of hepatitis c virus (HCV) infection in liver transplanted and non-transplanted patients. Birmingham: University of Birmingham, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Seminario, di aggiornamento sull'epatite da HCV: diagnosi epidemiologia prevenzione e. terapia (4th 1997 Rome Italy). IV Seminario di aggiornamento sull'epatite da HCV: Diagnosi, epidemiologia, prevenzione e terapia : Istituto superiore di sanità, Roma, 3-4 novembre 1997 : atti. Roma: Istituto superiore di sanità, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Käser, Elke Beatrice. Der Hallesche HCV-Impfschadensfall 1978/79 und die Verantwortung der Bundesrepublik Deutschland: Gleichzeitig ein Beitrag zu intertemporalkollisionsrechtlichen Fragestellungen auf einfachgesetzlicher und verfassungsrechtlicher Ebene. Leipzig: Leipziger Universitätsverlag, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Seminario, di aggiornamento sull'epatite da virus HCV e. nuovi virus potenzialmente epatitici: diagnosi epidemiologia prevenzione e. terapia (5th 2000 Rome Italy). V Seminario di aggiornamento sull'epatite da virus HCV e nuovi virus potenzialmente epatitici: Diagnosi, epidemiologia, prevenzione e terapia : Istituto superiore di sanità, Roma, 20-21 dicembre 2000 : atti. Roma: Istituto superiore di sanità, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Corporation, International Business Machines, red. I/O configuration using z/OS HCD and HCM. [S.l.]: Vervante, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Administration, United States Occupational Safety and Health. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). [Washington, D.C.?: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Kumar, Rajendra. HCI Human Computer Interaction: HCI. Wyd. 2. India: Laxmi Publications, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Wilson, Deanna. Hepatitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0035.

Pełny tekst źródła

Streszczenie:

Hepatitis A (HAV) and E (HEV) viruses are spread via the fecal-oral route. Hepatitis B virus (HBV) exposure is via occupational or recreational activities. Hepatitis D virus (HDV; also spread parentally) can only coinfect or superinfect those with chronic HBV. Hepatitis C (HCV) transmission is predominantly parenteral; the highest risk group is injection drug users. Prodromal-period patients with acute hepatitis present with vague constitutional symptoms when serum transaminases peak, with elevated serum bilirubin and varying levels of hepatic protein synthesis impairment; during the icteric phase, patients develop abdominal pain, hepatomegaly, and jaundice. Acute hepatitis has limited therapy; treatment is predominantly supportive. However, most adults with acute phase HAV, HBV, HDV, and HEV spontaneously clear the virus. Most individuals with HCV develop chronic hepatitis. Patients with known HAV, HBV, or HEV exposures may be eligible for post-exposure prophylaxis to reduce their risk of infection.

Style APA, Harvard, Vancouver, ISO itp.

27

Keshav, Satish, i Palak Trivedi. Viral hepatitis. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0212.

Pełny tekst źródła

Streszczenie:

Hepatitis means ‘inflammation of the liver’ and is manifest with symptoms that include malaise, anorexia, fever, flu-like symptoms, and pain in the right upper quadrant of the abdomen, with the pain being caused by swelling of the liver and its capsule. Elevations in circulating hepatic enzymes, particularly aspartate transaminase and alanine transaminase, are common, with jaundice occurring some time after the onset of other symptoms and signs. There are five viruses that primarily cause viral hepatitis: hepatitis A, B, C, D, and E viruses, abbreviated HAV, HBV, HCV, HDV, and HEV, respectively. These viruses are all hepatotrophic, in that the liver is the primary site of infection. HAV, HBV, and HEV are usually acute, self-limiting infections that may, nonetheless, cause morbidity and, in the case of HEV, fatality. However, HBV and, more so, HCV can cause chronic carriage of the virus over many years, as well as the development of chronic hepatitis. HDV is only pathogenic in conjunction with HBV. After recovery from acute infection with HAV, individuals have long-lasting immunity against further infection. The same holds true for the majority of individuals with acute HBV infection. There seems to be little natural immunity to HCV infection, and a significant proportion of cases result in chronic hepatitis. Immunity to HEV is not long-lasting, and repeated infections are possible. Many other viruses can cause hepatitis, of which cytomegalovirus, herpes simplex virus, Epstein–Barr virus, and flaviviruses such as dengue and yellow fever are the most important. The liver, however, is not their primary site of replication or cellular damage.

Style APA, Harvard, Vancouver, ISO itp.

28

HCV Testing. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Decision-Making in HIV/HCV Co-Infection. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Price, Jennifer Cohen, Priyanka Amin i Antoine Douaihy. Hepatitis C and HIV Co-Infection. Redaktorzy Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding i Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0043.

Pełny tekst źródła

Streszczenie:

Chronic infection with hepatitis C virus (HCV) is a leading cause of end-stage liver disease and is the most common indication for liver transplantation in the United States. Because of shared risk factors, individuals living with HIV infection are disproportionately affected by HCV. Moreover, co-infection with HIV accelerates the natural history of chronic HCV infection, increasing the risk of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and death. Highly effective medications such as direct-acting antivirals (DAA) to cure HCV are now available and have the potential to profoundly improve the health of HIV-HCV-co-infected individuals. However, addressing the many gaps in the HCV care cascade is necessary to fully achieve the benefits of these drugs. This chapter reviews the natural history of HIV-HCV co-infection, the psychiatric comorbidities associated with HCV infection, the evolution of HCV treatment, and the barriers to care that HIV-HCV-co-infected individuals continue to face.

Style APA, Harvard, Vancouver, ISO itp.

31

Ashm. Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Preventing HCV in Scotland. NHS Health Scotland, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Springer, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Decision Making in Hcv. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Decision-Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

HIV, STIs, HEPATITIS B (HBV) and HEPATITIS C (HCV) ISSUES for MEDICARE LOCALS. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Decision Making in HCV (Canada). Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

HCV and Related Liver Diseases. Springer, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Okita, Kiwamu. HCV and Related Liver Diseases. Springer London, Limited, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Hcv Treatments Quick Reference Tool. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Decision-Making in Hcv ¿ Portugal. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Okita, Kiwamu. HCV and Related Liver Diseases. Springer, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

HCV Treatment Quick Reference Tool. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Hsieh, Meng-Tien. HBV- and HCV-related hepatocarcinogenesis: Mechanisms and implication of treatment. 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Decision-Making in Hcv in Chicago. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Okita, K. HCV/Oxidative Stress and Liver Disease. Springer London, Limited, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

HCV TREATMENTS QUICK REFERENCE TOOL (Canada). Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Okita, K. Hcv/Oxidative Stress and Liver Disease. Springer, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!